Viewing nowAtorva 20 mg Tablet (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

MFDS item code 201310004 · Approved 2013.11.01 · Insurance code 652903400
Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. In particular, it reduces the risk of myocardial infarction and stroke, as well as the risk of heart-related issues such as vascular reconstruction or angina. It is also effective for diabetes patients or those with multiple risk factors. Additionally, it improves cholesterol and triglyceride levels in patients with primary hypercholesterolemia and dyslipidemia, and aids in increasing HDL cholesterol. This medication is used as an adjunct treatment to lower cholesterol levels in pediatric patients with familial hypercholesterolemia. Overall, it is used to improve heart and vascular health.
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment, and may take the drug at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring greater LDL-cholesterol reduction may start with 20 mg or 40 mg once daily (only when an LDL-cholesterol reduction of 45 % or more is required). This drug is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL-cholesterol, LDL-cholesterol levels are recommended for use at treatment initiation and when evaluating response. However, if LDL-cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL-cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years and older are generally similar to those in the general adult patient population.
10 ~ 17 years: The recommended initial dose is 10 mg of this drug daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this drug greater than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.
This medication should be discontinued immediately and a doctor consulted if any unusual muscle symptoms occur. Particular caution is needed if severe muscle pain, weakness, or cramps develop. This medication should not be used in patients with poor liver function or liver diseases, and regular liver function tests should be conducted. If symptoms of hepatitis or jaundice occur, medical personnel should be informed immediately. This medication should not be taken by women who are pregnant or may become pregnant, and by breastfeeding women. Women of childbearing potential should use appropriate contraception while taking this medication. This medication is not to be given to children under 10 years old or patients with specific genetic lactose intolerance disorders. As this medication has many drug interactions, it is crucial to consult with a doctor or pharmacist when taking it with certain antibiotics, antifungal agents, HIV treatments, and some antihypertensive medications. Elderly patients or those with reduced kidney function should be observed more closely due to an increased risk of muscle-related side effects while taking this medication. If symptoms such as muscle pain, weakness, or fever occur while taking this medication, the doctor should be informed immediately, and a blood test should be conducted. If significantly elevated serum creatine kinase levels are found, the medication should be discontinued. Taking this medication with grapefruit juice may increase blood concentration, increasing the risk of side effects, so it is advisable to avoid grapefruit juice. It is preferable to refrain from alcohol consumption during treatment and to undergo periodic liver function tests for liver health.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained between 1 to 30 degrees Celsius room temperature. This will help maintain the medication's effectiveness for a longer period.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.